India's Tatva Chintan Pharma hits upper circuit as Q1 profit more than doubles

Tatva Chintan Pharma Chem

20/07/2026 06:16

** Shares of Tatva Chintan Pharma Chem TATV.NS rise an exchange-allowed maximum of 20% to 1713.7 rupees, their highest price level since Sept. 2023
** Co's Q1 PAT jumps 140% Y/Y on strong demand for specialty chemicals; rev up 43%
** Q1 results a good start to FY27; provides confidence to achieve co's 25–30% Y/Y rev growth guidance -- ICICI Securities
** Over 2.1 mln shares traded, 43.4x the 30-day avg
** Stock up 28.4% YTD
     
     
     
     
     
     
     
     

 (Reporting by Aleef Jahan in Bengaluru)
 ((aleefjahan.cs@thomsonreuters.com))